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Abstract
The role of intrinsic and extrinsic healing in injured tendons is still debated. In this study, we characterized cell plasticity,
proliferative capacity, and migration characteristics as proxy measures of healing potential in cells derived from the
peritenon (extrinsic healing) and compared these to cells from the tendon core (intrinsic healing). Both cell populations
were extracted from horse superficial digital flexor tendon and characterized for tenogenic and matrix remodeling markers
as well as for rates of migration and replication. Furthermore, colony-forming unit assays, multipotency assays, and real-time
quantitative polymerase chain reaction analyses of markers of osteogenic and adipogenic differentiation after culture in
induction media were performed. Finally, cellular capacity for differentiation towards a myofibroblastic phenotype was
assessed. Our results demonstrate that both tendon- and peritenon-derived cell populations are capable of adipogenic and
osteogenic differentiation, with higher expression of progenitor cell markers in peritenon cells. Cells from the peritenon also
migrated faster, replicate more quickly, and show higher differentiation potential toward a myofibroblastic phenotype when
compared to cells from the tendon core. Based on these data, we suggest that cells from the peritenon have substantial
potential to influence tendon-healing outcome, warranting further scrutiny of their role.
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Introduction
Injuries to energy-storing tendons are prevalent in athletes as
well as in the general population. It has been estimated that
tendinopathy accounts for 30% to 50% of all injuries related to
sports [1]. The most common causes of tendon ailments are acute
trauma or repetitive activities that create an accumulation of
micro-injuries in the tendon tissue [2]. Tendinopathy is a result of
a deficient healing response to these accumulated micro-injuries in
the tendon tissues, which for largely unknown reasons are unable
to effectively regenerate [3]. Although many medical options are
available to treat tendon injuries, there is a high recurrence rate
and the prognosis for returning to previous performance levels is
still poor. A better understanding of the cellular mechanisms
involved in the natural healing of tendons could enable improved
medical treatment.
It was first suggested that tendons lack the capacity for intrinsic
healing and that in-growth of cells from the surrounding tissues is
necessary to enable healing of tendon injuries [4,5]. The tendon is
surrounded by the paratenon, a loose fibrillar tissue that functions
as an elastic sleeve permitting free movement of the tendon against
other tissues [6]. Under the paratenon, the entire tendon is
surrounded by a fine connective tissue sheath called epitenon [6].
The paratenon and the epitenon form together the peritenon.
Later work demonstrated the capacity of tendons to heal
intrinsically [7–10], and it is now believed that both intrinsic
and extrinsic healing play a synergistic role in tendon regeneration
[11,12]. However, the extent of the contribution of each is still not
well defined. While intrinsic healing capacity is commonly
reported as being inferior [13], it remains unknown whether this
could be due to a more limited regenerative capacity of the
resident cell population.
Another question that remains unanswered is whether aberrant
healing is related to the nature of cells migrating towards the
injured area, either from the surrounding tissue or from the tendon
core. Cells with a multi-lineage differentiation potential are
credited with the capacity to naturally remodel, repair, and
regenerate various tissue types when necessary [14]. However, the
multi-lineage differentiation potential of cells can also underlie
pathological processes when differentiation is not in accordance
with tissue function (ectopic differentiation) [15]. Fat deposition as
well as calcification has been observed in clinical cases of
tendinopathy [16,17]. Furthermore, during extensive tissue
remodeling, fibroblasts may acquire the phenotype of myofibro-
blasts. Briefly, myofibroblasts have stress fibers that incorporate
alpha smooth muscle actin (a-SMA), which facilitates forces
required for wound contraction [18]. Myofibroblasts also synthe-
size abundant amounts of collagen and are believed to be
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responsible for the formation of persistent scar tissue (fibrosis) and
the shrinkage of peritendinous tissue [19,20]
In this study, we compared the potential healing capacity of cell
populations carefully isolated from the tendon core or the
peritenon tissues of horse superficial digital flexor tendons (SDFT).
We first investigated differences in gene expression between these
two cell populations based on tenogenic markers. We then
compared their migration and replication rates, as well as their
capacity to produce collagen, as indicators of their healing
potential. Additionally, our interest was also to assess their
potential to differentiate towards osteogenic, adipogenic and
myofibroblastic phenotypes, as this might relate to their potential
to adversely affect healing outcome.
Methods
Isolation of cells from the core of the tendon and from
the peritenon
All animal tissues were obtained from animals being sacrificed
for food purposes and, by state (Canton of Zurich) and federal
(Swiss) regulations, no ethical approval was required. SDFTs were
collected from horses that had been freshly slaughtered for their
meat in local abattoirs (Boucherie chevaline Estavayer-le-lac and
Metzger Du¨rrena¨sch, both in Switzerland; permissions were given
from the slaughterhouses to use these animal parts). The horse
SDFT has a characteristic peritenon overlying the tendon core.
Cells were extracted either from the loose peritenon tissue or from
the core of the tendon, leaving 2 mm of the edge in order to obtain
two cell populations with clearly distinct tissue origins. Tendon
cells were isolated by digestion of the tendon matrix using Protease
Type XIV (Sigma-Aldrich, St. Louis, MO) for 2 h at 37uC and
Collagenase B solution (Roche, Burgess Hill, UK) for 16 h at
37uC. After matrix digestion, the mixture was filtered and
centrifuged at 400 g for 8 min at room temperature. The cell
pellet was re-suspended and cultured at 37uC, 5% CO2 in
expansion medium (Dulbecco’s modified Eagle’s medium
(DMEM), 10% fetal calf serum (FCS), 50 mg/ml gentamicin and
1.5 mg/ml fungizone (all from Life technologies, Paisley, UK)),
unless stated otherwise. Cells were cultured and trypsinized at
subconfluency and only cells freshly digested or from the first
passage were used for the experiments listed below. For ex vivo
differentiation experiments, explants of horse SDFT (size
106262 mm) with the peritenon still surrounding the tendon
were used.
Migration assay
For these experiments, cells from twelve different horses were
analyzed. Using 6-well plate dishes, cells were seeded at a density
of 10,000 cells/cm2 in each well and were maintained at 37uC and
5% CO2 for 6 days to permit cell adhesion and the formation of a
confluent monolayer. The confluent monolayer was then scored
with a sterile pipette microtip to leave a scratch of ,0.4–0.5 mm
in width. The scratch areas were monitored on an inverted Zeiss
microscope (Observer Z1, Oberkochen, Germany) by collecting
digitized pictures at various time points until closure was complete.
The images were then analyzed using Image J software (National
Institute of Health, Bethesda, MD). All scratch assays were
performed in duplicate. The migration rate was calculated by
dividing the newly covered area by twice the width of the lesion in
order to determine the average distance the cells had covered to
close the wound. This distance was then divided by time to
calculate the migration speed in mm/h.
Replication assay
Tendon and peritenon cells (passage 0) from four different
horses were plated at 10,000 cells/cm2 in 3 flasks each. After 7
days in culture, the cells were trypsinized and counted using
Trypan blue to exclude dead cells.
Colony-forming unit assay
Tendon and peritenon cells from seven horses were plated at
50 cells/cm2 in Petri dishes. After nine days in culture, colonies
were counted and characterized as previously described by
Franken et al. [21]. Briefly, cells were rinsed with PBS, fixed in
4% paraformaldehyde, stained with 0.5% crystal violet for 30 min
and rinsed twice with water. Size and number of the colonies were
evaluated.
Differentiation experiments
Eight horses were used for differentiation experiments. For
tenogenic control cultures, the cells were cultivated in expansion
medium with a seeding density of 10,000 cells/cm2. The medium
was renewed every 2–3 days and the cells were kept in a 5% CO2
environment at 37uC. To induce differentiation, we followed
protocols established by others [22]. Briefly, to induce osteogenic
differentiation, the cells were seeded at a density of 3,000 cells/
cm2 and cultured in DMEM High Glucose with Glutamax (Life
technologies), 10% FCS (Life technologies), 0.6% fungizone (Life
technologies), 0.1% gentamicin (Life technologies) and freshly
added 10 mM glycerol phosphate (Sigma-Aldrich), 0.1 mM
dexamethasone (Sigma-Aldrich) and 0.1 mM L-ascorbic acid 2-
phosphate (Sigma-Aldrich). To induce adipogenic differentiation
cells were seeded at 20,000 cells/cm2 and the induction medium
consisted of DMEM Glutamax (Life technologies) with 10% FCS
(Life technologies), 0.6% fungizone (Life technologies), 0.1%
gentamicin (Life technologies) and freshly added 0.1 mM dexa-
methasone (Sigma-Aldrich), 0.2 mM indomethacin (Sigma-Al-
drich), 0.01 mg/ml insulin (Sigma-Aldrich) and 0.5 mM 3 iso-
butyl-1-methyl-xanthine (Sigma-Aldrich). The cells were kept for
21 days in a 5% CO2 environment at 37uC and the differentiation
media were refreshed twice a week.
Histological and immunohistochemical stainings
Pretreatment for staining. The seeded cells were fixed with
3% formaldehyde for 15 min and then washed with PBS before
further treatment. The paraffin embedded explants were cut in
6 mm sections and those sections were deparaffinized by succes-
sively dipping them for 5 min in Histoclear (National Diagnostics,
Atlanta, GA), 100% ethanol, 96% ethanol, 70% ethanol and
finally cleared in distilled water before further staining.
Alizarin red S staining. Cells were stained with Alizarin red
S (Sigma-Aldrich) for 2 min and washed with microfiltered and
deionized water. Paraffin sections were additionally and briefly
immersed in acetone, then in an acetone-xylene (1:1) solution and
cleared in xylene. All samples were then counterstained with
Mayer’s hematoxylin for 5 min and rinsed in distilled water.
Stained cells that contained mineral deposits appeared orange-red
under the microscope.
Oil red O staining. Paraffin sections were first briefly dipped
in 60% 2-propanol before starting the staining with Oil red O
(Merck, Whitehouse, NJ) for 20 min and then dipped again in
60% 2-propanol and finally washed with distilled water. The
seeded cells were directly stained with Oil red O. All samples were
then counterstained with Mayer’s hematoxylin for 5 min and
repeatedly washed with tap water. Stained lipid droplets appeared
red under the microscope.
Comparison of Peritenon versus Tendon Core Cells
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Gene expression analysis
Real time RT-PCR was used to monitor the differentiation
potential of the two cell populations in the three lineage-specific
induction media. Eight horses were used for analysis of the gene
expression. Every sample was tested in triplicate for each gene. We
used the following primers (Table 1) to determine the gene
expression of the seeded cells: Col1A1, TNMD and SCX were
chosen as tenogenic markers; Col3A1, MMP1 and MMP3 were
considered as matrix remodeling markers; Runx2 and Sp7 were
selected as osteogenic differentiation markers; PPARG and Fabp4
were used as markers of adipogenic differentiation; and Oct-4,
CD34, CD45, CD90 and CD105 were chosen as progenitor cell
markers [23–25]. GAPDH, b-actin and B2M were selected as
internal controls (housekeeping genes) based on existing literature
on optimal housekeeping genes for RT-PCR in the equine species
[26].
RNA isolation and real time RT-PCR. Medium was
removed from the wells and cells were suspended in RNA-Bee
(Tel-test, Friendswood, TX). Cells’ RNA was then isolated using
RNeasy Micro Kit 50 (Qiagen, West Sussex, UK) with on-column
DNAase digestion. Total RNA content was determined spectro-
photometrically using a NanoDrop (Thermo Fisher Scientific,
Waltham, MA). The RNA obtained was further reverse-
transcribed into cDNA with a RevertAid First Strand cDNA
Synthesis Kit (Fermentas, Thermo Fisher Scientific). Finally, real
time RT-PCR was performed using a real time PCR system
thermal cycling block (StepOnePlus, Applied Biosystems, Carls-
bad, CA) with Power Sybr green PCR master mix (Applied
Biosystems) and standard software (StepOne version V2.1,
Applied Biosystems).
RT-PCR data processing. Data were normalized to three
housekeeping genes (GAPDH, b-actin and B2M) that were stably
expressed across sample conditions (with the exception of
osteogenic and adipogenic induction experiments, for which only
GAPDH was stably expressed and alone used for normalization).
Relative expression and fold-change expression were calculated
according to the 2-DDCT formula [27] using pooled triplicate
samples (average of triplicate wells), and normalized to group
median expression. Experimental groups with median CT values
above 30 were considered to have low or negligible gene
expression, and all presented data or derivative fold change
calculations are indicated as such. Statistical analysis was
Table 1. Designed primers.
Primer Coded Protein
Length (base
pairs) Primer sequence (59 -.39)
Tenogenic markers
COLIA1 (XM_001499586.3) Collagen type I 164 F:TGCCATCAAAGTCTTCTGCAA R:CGCCATACTCGAACTGGAATC
TNMD (NM_001081822.1) Tenomodulin 142 F:AGAAGACCCGTCGCGCCAGA R:CGGCAGTAGCGGTTGCCTCG
SCX (NM_001105150.1) Scleraxis 81 F:GCCGGTCACATCCCTCGCCA R:TCCTCCGACAGCGGGCTCAC
Matrix remodeling markers
COL3A1 (XM_001917620.2) Collagen type 3 150 F:TACTTCTCGCTCTGCTTCATCC R:GAACGGATCCTGAGTCACAGAC
MMP1 (NM_001081847.2) Matrix metalloproteinase 1
(interstitial collagenase)
92 F:CGAAGGGAACCCTCGGTGGGA R:TGGCCTGGTCCACATCTGCTC
MMP3 (NM_001082495.2) Matrix metalloproteinase 3
(stromelysin 1, progelatinase)
139 F:TTTTGGCCATCTCTTCCTTCA R:TGTGGATGCCTCTTGGGTATC
Progenitor cells markers
OCT4 (XM_001490108.4) Octamer-binding transcription factor 4 149 F:AACCACACTCGTACCACGTC R:GCCCGAAAGAGAAAGCGAAC
CD34 (XM_001491596.2) Cluster of differentiation 34 155 F:AGCACTATTCCCGCAAGACC R:TCCACCGTTCTCCGTGTAAC
CD45 (XM_005608047.1) Cluster of differentiation 45 or
PTPRC (Protein tyrosine phosphatase,
receptor type, C)
206 F:ATTCCACGGGTGTTCAGCAA R:GGACCTTGGGCAGCAATGTA
CD105 (XM_003364144.2) Cluster of differentiation 105 104 F:GCAGCACCTACTCCAACTGT R:CACCTTTTTCCGCTGTGGTG
CD90 (XM_001503225.2) Cluster of differentiation 90 82 F:CAGAAGGTGACCAGCCTGA R:GTGTGGCGGTGGTATTCTCA
Differentiation markers
RUNX2 (XM_001502519.3) Runt-related transcription factor 2 81 F:CCCACGGCCCTCCCTGAACT R:TGTGCCTGCCTGGGGTCTGT
SP7 (XM_001494930.3) Transcription factor osterix,
transcript variant1
130 F:GATGGCGTCCTCCCTGCTTGA R:GCCTGCTTTGCCCAGTGTCGT
PPARG (XM_001492430.1) Peroxisome prolifertor-activated
receptor gamma-like, transcript
variant 2 (LOC100051258)
185 F:AGGGGCCTTTACCTCTGCTGGT R:TGGGCCAAAATGGCATCTCCGT
FABP4 (XM_001490771.3) Fatty acid-binding protein,
adipocyte-like (LOC100057425)
195 F:ACACCAGAGGGTCAGACACCT R:GGTTTGGCCATGCCAGCCAC
House-keeping genes
GAPDH (NM_001163856.1) Glyceraldehyde-3-phosphate
dehydrogenase
141 F:GTCAACGGATTTGGTTATTGGG R:TGCCATGGGTGAATCATATTGG
bACTIN (NM_001081838.1) Beta-actin 107 F:CACCACACCTTCTACAAC R:ATCTGGGTCATCTTCTCG
B2M (NM_001082502.2) Beta-2-microglobulin 271 F:GGCTACTCTCCCTGACTGG R:ACACGGCAACTATACTCATCC
doi:10.1371/journal.pone.0092474.t001
Comparison of Peritenon versus Tendon Core Cells
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performed using SPSS 11.5 software (SPSS Inc., Chicago, IL).
Fold change values are presented as Box-Whisker plots, with the
boxes representing the middle two quartiles (25–75) and the
whiskers representing the highest and lowest data point values.
Western Blotting
The cells from three different horses were lysed in sample buffer
(0.1 g/ml SDS (Biosolve BV, Valkenswaard, NL), 1 M Tris-HCl
(Biosolve BV), 50% glycerol (Sigma-Aldrich)). Equal amounts of
proteins were analyzed by Western blotting using antibodies to
collagen type I (Abcam, Cambridge, UK), scleraxis (Abcam), a-
SMA ((mouse IgG2a, clone SM1) kind gift of Prof. Christine
Chaponnier and Prof. Giulio Gabbiani, University of Geneva,
Switzerland [28]) and vimentin (DAKO, Glostrup, Denmark).
The band signal strengths in Western blots were further analyzed
by optical densitometry and related to loading control vimentin.
The experiments were run in triplicate.
Myofibroblast differentiation
The potential of the two cell populations to differentiate toward
a myofibroblastic phenotype was assessed by comparing relative
expression of a-SMA in cells in culture with the presence or
absence of transforming growth factor beta 1(TGF-b1 (2 ng/ml);
R&D systems, Minneapolis, MN). TGF-b1 is known to elicit the
expression of a-SMA, the most frequently used marker of
myofibroblasts. Additionally, the differentiation potential of the
two cell populations was also tested on different ligands. Peritenon
cells as well as cells from the core of the tendon from three
different horses were seeded on 100 kPa Polydimethylsiloxane
(PDMS; ExCellness Biotech SA, Lausanne, Switzerland) coated
with collagen (Sigma-Aldrich) or fibronectin (EMD Millipore,
Billerica, MA). The differentiation potential toward a myofibro-
blastic phenotype was then determined for both cell populations
using the Western blot techniques described above.
Statistical analysis
Related Samples Wilcoxon Signed Rank tests were used to
assess differences among conditions. Significance level was set at
p,0.05.
Results
Comparison of gene expression in both populations of cells for
tenogenic markers (SCX, TNMD and COL1A1; fig. 1) showed
that cells from the core of the tendon expressed significantly higher
amounts of SCX (24-fold; p = 0.01), with statistically indistin-
guishable amounts of COL1A1 expression in the two cell
populations (p = 0.48). Expression of TNMD was very low (CT
values .34) in all samples and statistically indistinguishable.
Western blot results for scleraxis and collagen type I confirmed the
gene expression data for the corresponding genes.
Looking further at expression of genes involved in tendon
extracellular matrix remodeling, cells from the peritenon ex-
pressed higher amounts compared to cells from the tendon core
for COL3A1 (2.1-fold; p = 0.02), MMP1 (330-fold; p = 0.02; with
minimal expression in tendon cells) and MMP3 (13-fold; p = 0.02).
Looking at progenitor cell markers (fig. 2), cells from the
peritenon expressed significantly higher amounts of CD45 (31-
fold; p = 0.03; with low expression in tendon core cells), CD90
(1.9-fold; p = 0.02), CD105 (2.4-fold; p = 0.02), and Oct-4 (2.6-
fold; p = 0.02; with low expression in both cell types), compared to
cells from the tendon core. CD34 was expressed in both
populations in negligible amounts and with no significant
difference between the two populations (data not shown).
To test the hypothesis that peritenon cell populations demon-
strate enhanced propensity for migration, confluent populations of
cells from the tendon core and peritenon were monitored using a
scratch assay. Peritenon cells showed significantly faster wound
closure (1.2-fold; p = 0.04) compared to cells from the tendon core
(fig. 3). Additionally, we evaluated the replication rate of the two
cell populations. After 7 days, we counted 33% more cells in the
peritenon population compared to the cell population from the
core of the tendon (p = 0.03; fig. 3).
Clonogenicity, multipotency and self-renewal are widely used
criteria to define stem cells. To characterize clonogenicity, cells
from the tendon core and from the peritenon were seeded at a low
density. During the first 2 days, the cells of both populations
adhered but stayed quiescent. A small percentage of both
populations of cells formed colonies on day 9 (fig. 4A,B). Cells
from the tendon core formed 2.6 times more colonies than cells
from the peritenon (p = 0.02; fig. 4C). Based on the assumption
that each observable colony originates from a single progenitor
cell, these data indicate a significantly higher proportion of
progenitor cells in the tendon core population than in the cell
population from the peritenon. The size of the colonies observed
varied within one population, however the colonies formed by cells
from the peritenon were overall larger (1.82 mm260.4 mm2 and
0.74 mm260.2 mm2 for peritenon and core cell populations,
respectively (2.5-fold increase; p = 0.02; fig. 4D)) indicating higher
proliferative capacity of peritenon progenitor cells and their
progeny, despite formation of relatively lower numbers of colonies.
As tendons are derived from mesoderm origins, which also give
rise to bone and fat, the adipogenic and osteogenic potential of the
cells was tested using specific media and cell densities. When
cultured in osteogenic medium, both populations showed an
ability to differentiate towards bone (fig. 5A–D). Using Alizarin red
staining, larger calcium plaques were observed for the population
of peritenon cells (fig. 5C). The control conditions were devoid of
observable calcium deposits (fig. 5B,D). Like the cell population
from the tendon core, the peritenon cell population showed a
heterogeneous differentiation potential toward adipogenic and
osteogenic phenotypes. When cultured in adipogenic medium,
cells from both populations exhibited numerous lipid droplets at
day 21 (fig. 5E–H), indicating their ability to differentiate toward
an adipogenic phenotype. Correspondingly, cell morphology
drastically changed from a fibroblast-like spindle shape to a round
shape. Oil red O staining revealed no clear differences between the
two cell populations in adipogenic differentiation medium. No
lipid droplets were found in the cells from either of the populations
grown in a control medium lacking adipogenic supplements
(fig. 5F,H). At the level of gene expression, no significant difference
was observed for either the osteogenic markers Runx2 or SP7 in
either osteogenic medium or control medium (fig. 6A,B). The
expression of the adipogenic markers FABP4 and PPARG was
significantly increased for both populations in adipogenic medium
compared to the control medium. Median FABP4 expression
increased by 47’000-fold and 83’400-fold for cell populations from
the tendon core and from the peritenon, respectively, reflecting
negligible expression of fat markers before activation in adipogenic
medium (p,0.05). Median PPARG expression showed a 66-fold
increase for the cell population from the tendon core and a 23-fold
increase for the cell population from the peritenon (p,0.05). The
cells from the core of the tendon had a significant increase (3.8-
fold) in expression for PPARG in the adipogenic condition
compared to the cells from the peritenon (p= 0.03), although
baseline expression of PPARG was higher in peritenon cells.
FABP4 expression showed no significant differences between the
two cell populations in adipogenic medium.
Comparison of Peritenon versus Tendon Core Cells
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Additional explant experiments were undertaken to investigate
how cells in their intact matrix would react to adipogenic and
osteogenic differentiation media. Here, horse SDFT explants with
their intact peritenon sheath were cultured for 21 days. Under
adipogenic conditions, Oil red O staining revealed no changes for
cells inside the tendon core that remained aligned along the
collagen fibers (fig. 7A) In contrast, cells at the edge of the explants
as well as those in the endotenon and peritenon showed a response
to the differentiation medium. Numerous cells showed an enlarged
and rounded shape. Similarly the cells in the dense, intact matrix
of the tendon core were not affected by the osteogenic
differentiation medium, whereas cells in the endotenon and
peritenon showed a positive staining for Alizarin red (fig. 7B). The
cell density in these regions also appeared to have dramatically
increased.
The propensity for myofibroblast differentiation was investigat-
ed by monitoring the level of a-SMA, a protein involved in the
heightened contractility that characterizes myofibroblast behavior.
In both cell populations, the presence of myofibroblasts in the
original population could be demonstrated in vitro, even prior to
stimulation with TGF-b1 (fig. 8A). More a-SMA levels were
observed in the original population of cells isolated from the
tendon core compared to the original peritenon cell population. As
expected, the level of a-SMA increased for both populations of
cells after the addition of TGF-b1 (a-SMA expression was
increased 2.4 times for the cell population of the tendon core
and 3.6 times for the cell population of the peritenon; fig. 8B).
However, the level of a-SMA was 1.2 times higher in the
peritenon cell population, indicating a higher differentiation
potential towards myofibroblasts when compared to the cell
population from the core (fig. 8B).
When seeded in presence of TGF-b1 on PDMS substrates
(100 kPa) coated with collagen type I, the cell population from the
peritenon showed a higher level of a-SMA (1.7 fold) compared to
the cell population from the tendon core (fig. 8C). This non-
significant tendency was augmented when the cells were seeded on
PDMS coated with fibronectin, an extracellular matrix protein
typical within injured tendons [29]. The cell population from the
peritenon showed a 4-fold increase of a-SMA expression on
fibronectin compared to the cell population from the tendon core
(fig. 8D).
Discussion
We have evaluated two cell populations of different origin for
proxy measures of their potential healing capacity as well as for
their potential involvement in pathogenesis. One population was
directly derived from the core of the tendon (related to intrinsic
healing) and the other came from the surrounding tissues of the
tendon, the peritenon (extrinsic healing).
Tenogenic gene expression analysis showed distinctive profiles
for each of the two cell populations. The cell population from the
tendon core demonstrated a significantly higher expression of the
gene coding for scleraxis when compared to the cell population
coming from peritenon, similar to observations that have been
made in murine Achilles tendon [11]. We observed no differential
expression of the gene coding for tenomodulin, with TNMD
expression being very low in both populations after their
extraction.
Analysis of matrix remodeling-related gene expression, and
measurements of replication and migration rates all indicated a
faster reactive potential for cells from the peritenon compared with
cells from the tendon core. These results are in accordance with
Figure 1. Gene expression levels of tenogenic markers, matrix remodeling markers, and western blots on tenogenic markers to
confirm gene expression results. Gene expression of (A) SCX, (B) TNMD, (C) COL1A1, (D) COL3A1, (E) MMP1, and (F) MMP3 in tendon core cell
population and peritenon cell population cultured in expansion medium. The cells were extracted from eight different horses. Using the 22DDCT
method, the data are presented both in terms of ‘‘relative expression’’ normalized to three housekeeping genes, as well as the fold change in gene
expression normalized relative to the tendon core expression. The respective p values are as follows:(A) SCX (24-fold; p = 0.01), (B) TNMD low
expression and not significantly different, (C) no difference for COL1A1 (p = 0.48) (D) Col3A1 (2.1-fold; p = 0.02), (E) MMP1 (330-fold; p = 0.02), (F)
MMP3 (13-fold; p = 0.02. (G) Western blots on tenogenic markers to confirm the gene expression results. The graphs display the relative band signal
strength in Western blots analyzed by optical densitometry and related to loading control vimentin. Cells from the tendon core population
demonstrated a higher level of scleraxis protein expression compared to cells from the peritenon when cultured in expansion medium for a week
(p,0.05). The difference between the two cell populations for collagen protein expression was not significant.
doi:10.1371/journal.pone.0092474.g001
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Figure 2. Gene expression levels of progenitor cell markers, indicates higher levels of progenitor cell markers in peritenon cell
populations. (A) CD45 (31-fold; p = 0.03), (B) CD90 (1.9-fold; p = 0.02) (C) CD105 (2.4-fold; p = 0.02), and (D) Oct-4 (2.6-fold; p = 0.02).
doi:10.1371/journal.pone.0092474.g002
Figure 3. Migration and replication rate. (A) Average migration speed of the cell populations from the core of the tendon and from the
peritenon, obtained with a scratch assay monitored over 8 h. The peritenon cell population was 1.2 times faster than the tendon core population (p
= 0.04). The cells were from twelve different horses. (B) Replication rate: Starting with equivalent numbers of cells, we calculated the number of cells
after 7 days in culture in expansion medium. There were 1.33 times more cells in the flasks containing cells isolated from the peritenon compared to
the flasks containing cells isolated from the tendon core (p = 0.026). The cells were from four different horses.
doi:10.1371/journal.pone.0092474.g003
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functional in vivo studies in which cells from the epitenon have been
observed to proliferate and migrate towards and into the wound
[30–33]. The finding of similar levels of expression for Col1A1
(also confirmed at protein level) but increased levels for Col3A1
and MMP1 and MMP3 in the peritenon cell population compared
to the tendon core population is consistent with the concept of
Figure 4. Clonogenicity of the two cell populations. Representative wells with colonies from the tendon core population (A) and from the
peritenon population (B) were evaluated (n = 14; the cells were from seven different horses; scale bar = 0.5 cm). The cells isolated from the tendon
core demonstrated 2.6 times more colonies compared to the peritenon cell population (C; p = 0.02). The colonies were 2.5 times larger in the
peritenon cell population than in the cells isolated from the tendon core (D; p = 0.018).
doi:10.1371/journal.pone.0092474.g004
Figure 5. Potential for osteogenic and adipogenic differntiation of cells from the tendon and peritenon after 21 day culture in
induction medium. Osteogenic (Alizarin Red; A–D) and adipogenic (Oil red O; E–H) differentiation of cells from the core of the tendon and from the
tendon core (A,B; E,F) and from the peritenon (C,D; G,H). Larger calcification nodules (black arrows) were observed in the peritenon cell population (C)
compared to the cells isolated from the tendon core (A) in osteogenic medium. Controls lacked nodule formation (B,D). Lipid vacuoles (black arrows)
inside the cells of both populations when cultured in adipogenic medium (E,G), but not in the control condition with expansion medium (F,H). Scale
bar = 100 mm.
doi:10.1371/journal.pone.0092474.g005
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peritenon-mediated extrinsic repair of tendon collagen structures,
for instance after tendon suturing [30]. We were able to confirm
these characteristics with controlled parameters in vitro. Taken
together, these results suggest a dual healing process with a
possible predominance of extrinsic healing.
While stem cells are heavily involved in homeostasis, growth
and repair of many tissues [34], they may also contribute to some
forms of tendinopathy by creating ectopic tissue inside the tendon
[35].Our RT-PCR analyses demonstrated that the cells from the
peritenon had significantly higher expressions of the following
Figure 6. Gene expression of markers for osteogenic and adipogenic induction. Fold changes were calculated by dividing the relative
expression of the gene of interest in the differentiation medium by the relative expression in the control expansion medium. No significant
differences were found for osteogenic markers, either between induction and control media or between cell types (A,B). With respect to the
adipogenic markers (C,D), both markers were substantially upregulated in induction medium. No significant difference was found between cell
populations for FABP4 (C), while PPARG (D) was significantly upregulated (3.8-fold) in the cells isolated from the tendon core compared to the cell
population from the peritenon (p,0.03); The cells were extracted from eight horses).
doi:10.1371/journal.pone.0092474.g006
Figure 7. Cells at the margins of a tendon explant, but not those inside the more densely packed, well-organized intact matrix,
show propensity for differentiation to non-tendinous phenotypes. Arrows indicate cells that are stained for markers of differentiation in
adipogenic medium (Oil red O staining; row A) and osteogenic induction medium (Alizarin red S staining (row B). Images correspond to the edge of
the sample, the middle of the explant section and in the endotenon (columns from left to right). Differentiated cells (black arrows) appear in the
endotenon and peritenon, but not in the tendon core. Explants were analyzed from six different horses.
doi:10.1371/journal.pone.0092474.g007
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genes: CD45, CD90, CD105, and Oct-4 compared to the cells
from the tendon core. None of the populations expressed CD34
and only cells from the peritenon expressed CD45. Gene
expression of CD90 and CD105 are accepted markers for human
and equine mesenchymal stem cells (MSC) [23–25]. Oct-4 has
been used as an MSC marker for cells originating from adipose
tissue, bone marrow and umbilical cord [25,36–38] and CD45
and CD34 are used as markers to differentiate MSC from
hematopoietic stem cells. Taken together, these results suggest a
higher proportion of MSC and the presence of hematopoietic stem
cells in the cells population from the peritenon compared to the
population originating from the tendon core. Our assays of
clonogenicity indicated a slightly ambiguous result, with fewer but
substantially larger colonies formed in cell populations from the
peritenon compared to the cell populations from the tendon core.
While these data suggest a potentially higher proliferative rate of
stem/progenitor cells in the peritenon cell population, additional
investigations (e.g. fluorescence activated cell sorting (FACS)
analysis of surface markers) to more accurately quantify progenitor
cells are warranted. Our results also indicated increased formation
of calcium deposits after differentiation in osteogenic media for
peritenon cell populations compared to populations extracted
from the tendon core. However this qualitative difference in
calcium deposition was incongruous with statistically equivalent
gene expression of osteogenic markers. Similarly, potential for
adipogenic differentiation appeared roughly equivalent for both
cell populations. Collectively these data clearly suggest the
existence of stem/progenitor cells in both populations, but with
greater migration rates, proliferative capacity, and a possibly
higher potential for calcium formation in cell populations
extracted from the peritenon. These findings are consistent with
those of Mienaltowski et al., who reported that the number of
colonies formed by progenitor cells from the tendon core was
higher than from the peritenon in mouse Achilles tendon [11]. As
in the present study, these authors also did not observe any clear
difference regarding adipogenic differentiation potential between
Figure 8. Comparison of the propensity to differentiate into myofibroblasts of the cell populations from the peritenon and from
the core of the tendon and the effects of ligands on the differentiation propensity of cells isolated from the peritenon and cells
isolated from the tendon core. (A–C) Expression of myofibroblast marker a-SMA was assessed by Western blotting together with loading control
vimentin. (B–D) Band signal strength in Western blots was analyzed by optical densitometry and related to loading control vimentin. (A–B)Following
addition of TGF-b1, the level of a-SMA was 2.4 times increased in the cell population from the tendon core and 3.6 times increased in the cell
population from the peritenon. The cell population from the peritenon showed a 1.2-fold increased expression of a-SMA compared to the cell
population from the tendon core when cultured with TGF-b1. (C–D) The cell population from the peritenon showed a 1.7-fold increase of a-SMA
expression on 100 kPa PDMS dishes coated with collagen compared to the cell population of the tendon core and a 4-fold increase of a-SMA
expression on same dishes coated with fibronectin (for both experiments, the cells were extracted from three different horses).
doi:10.1371/journal.pone.0092474.g008
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the two cell populations. One interesting distinction between our
results and those of Mienaltowski et al. is that they did not observe
any calcium deposits in the cell population from the peritenon
whereas we observed clear calcification in this cell population
In contrast to one other report [39], we did not detect
adipogenic markers in cells cultured in control medium. One
plausible explanation for this discrepancy could be that equine
tendon cells display a different behavior from those of rodents,
paralleling similar differences in adipogenic and osteogenic
potential of tendon/stem progenitor cells between mice and
humans [40]. Species-related specificity in differentiation may also
explain why, unlike in human tendons, clinical observations of
lipid accumulation in diseased or injured equine tendons have not
yet been reported [41].
We observed that cells at the margins of a tendon explant, but
not those inside the more densely packed, well-organized intact
matrix, show propensity for differentiation to non-tendinous
phenotypes. This suggests that a well-structured matrix may play
a key role in regulating the fate of stem/progenitor cells, with
possible implications for adipogenesis in tendinopathy, and ectopic
calcifications. Previous in vitro studies using cross-linked collagen
matrices and gels have also shown a clear influence of matrix
compliance in directing the stem cell lineage specifications [42,43].
To our knowledge, our study is the first to show the influence of
the matrix in tendons ex vivo.
Myofibroblasts are key players in the classic connective tissue
wound healing paradigm but are also associated with excessive
scar formation [44,45]. Little is known of the role of myofibro-
blasts in healing tendons [46]. Our results reveal the presence of a-
SMA in native cell populations of both tissue compartments in
vitro, with higher levels observed in cells from the tendon core. In
theory, these observations might be explained in part by the
presence of pericytes (contractile cells lining blood capillaries)
within the sampled populations and not necessarily by a
differentiation of fibroblastic cells, such as tenocytes, into
myofibroblasts. However, tendons are poorly vascularized, as
confirmed by De Mos et al. who found that 98.560.7% of the cells
isolated from tendons were negative for CD34, an endothelial cell
marker [15]. More importantly for the present investigation, a-
SMA expression increased in both cell populations after the
addition of TGF-b1, with the peritenon-derived cell population
showing a greater potential to differentiate into myofibroblasts.
Furthermore, our findings indicated increased a-SMA levels in
cells seeded on fibronectin-coated substrates compared to colla-
gen-coated ones, suggesting a high affinity for fibronectin, which is
abundantly found in healing tendons [29]. These results indicate
again that the cells from the peritenon are highly reactive cells. It is
therefore very plausible that they are implicated in tendon healing
processes.
Aside from careful anatomical extraction, we did not localize
the origin of cells showing a clear tenogenic phenotype or stem/
progenitor cell markers. Consequently, we were not able to
evaluate the proportion of those cells in the population from the
core of the tendon that had come from the endotenon. We were
also not able to distinguish between individual cells with multi-
lineage potential and more or less strongly committed cells. We did
find that not all of the cells showed a clear differentiation towards
other lineages (osteogenic, adipogenic and myofibroblastic), which
indicates that there were different subpopulations within the larger
populations of cells extracted from these two tissue sources. While
surface marker analysis of the cells could provide additional
clarification in future studies, FACS analysis of mature tendon
cells and their progenitors is currently limited with established
surface markers only now emerging [15]. Still, the functional data
we provide give further evidence for other studies where stem/
progenitor cells have been reported to originate from the tendon
core [15,39,40,47] and from the peritenon [11]. Our data also
confirm the reportedly higher reactivity of stem/progenitor cells
from the peritenon compared with those from the tendon core
[11]. Beyond previous studies, our study is the first to indicate a
higher differentiation potential towards a myofibroblastic pheno-
type for the cells from the peritenon in comparison with cells from
the core of the tendon. This suggests that there may be a greater
potential of cells from the peritenon to be involved in formation of
scarring and adhesions during tendon healing. We also investi-
gated for the first time the role of a native (explanted) 3D tendon
matrix in influencing cell differentiation towards adipogenic or
osteogenic lineage and we showed a clear protective effect of an
intact matrix. More importantly, our results show that both the
cells from the peritenon and the cells from the core of the tendon
were able to express and produce large amounts of collagen type I,
indicating a possible dual mechanism (intrinsic and extrinsic) for
tendon healing.
Taken together, these findings highlight an unexpectedly large
plasticity of both tendon and peritendinous cells – with potentially
important implications for tissue repair mechanisms. These
mechanisms are central to our understanding of the onset and
development of tissue pathologies such as tendinopathy, and the
eventual development of improved therapeutic strategies.
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